Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study

Go back to Resources

The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The effect of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Three-year results

Go back to Resources

The effect of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Three-year results

Authors:

Location:

Go back to Resources

Tacrolimus vs cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study

Go back to Resources

Tacrolimus vs cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas

Go back to Resources

Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis

Go back to Resources

Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis

Authors:

Location:

Go back to Resources

Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report

Go back to Resources

Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report

Authors:

Secondary:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax

Go back to Resources

Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Six-month results of the first, prospective, randomized, multi-center kidney transplant study comparing tacrolimus+ Rapamune vs tacrolimus+ MMF combination therapy

Go back to Resources

Six-month results of the first, prospective, randomized, multi-center kidney transplant study comparing tacrolimus+ Rapamune vs tacrolimus+ MMF combination therapy

Authors:

Go back to Resources

Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers

Go back to Resources

Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

RSV Hospitalization and prophylaxis: Influence of baseline demographics and risk factors on outcomes in the 2001-2002 Synagis® Outcomes Registry

Go back to Resources

RSV Hospitalization and prophylaxis: Influence of baseline demographics and risk factors on outcomes in the 2001-2002 Synagis® Outcomes Registry

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • Current page 158
  • Page 159
  • Page 160
  • Page 161
  • Page 162
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification